Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 332,795 | 322,244 | 264,530 | 211,669 | 199,389 |
| Depreciation Amortization | 13,003 | 18,562 | 12,916 | 14,653 | 11,324 |
| Income taxes - deferred | 17,251 | -19,842 | -999 | 11,338 | 31,217 |
| Accounts receivable | 300 | N/A | N/A | 234 | -131 |
| Accounts payable and accrued liabilities | 76 | 31 | -787 | 546 | -2,012 |
| Other Working Capital | 9,191 | 8,635 | -13,178 | -25,807 | -73,181 |
| Other Operating Activity | -71,151 | -37,349 | 7,263 | -127 | 3,176 |
| Operating Cash Flow | $301,465 | $292,281 | $269,745 | $212,506 | $169,782 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -148,708 | N/A | N/A |
| PPE Investments | -9 | -49 | -2 | -51 | N/A |
| Purchase Of Investment | N/A | -1,750 | -9,875 | -29,898 | -74,744 |
| Sale Of Investment | 1,947 | 3,530 | 43,780 | 50,831 | 50,696 |
| Purchase Sale Intangibles | -71,593 | 21,360 | -241,314 | N/A | N/A |
| Other Investing Activity | -81,586 | -139,840 | -182,035 | -92,590 | 0 |
| Investing Cash Flow | $-79,648 | $-138,109 | $-296,840 | $-71,708 | $-24,048 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 100,000 | N/A | 74,169 | N/A | N/A |
| Debt Issued | N/A | 300,000 | N/A | 0 | N/A |
| Debt Repayment | -220,397 | -56,191 | N/A | -93,370 | -244,751 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 149,712 |
| Dividend Paid | -98,307 | -96,557 | -84,006 | -83,942 | -83,828 |
| Other Financing Activity | -75,607 | -104,349 | 22 | -818 | -9,897 |
| Financing Cash Flow | $-294,311 | $42,903 | $-9,815 | $-178,130 | $-188,764 |
| Beginning Cash Position | 291,377 | 94,302 | 131,212 | 168,544 | 211,574 |
| End Cash Position | 218,883 | 291,377 | 94,302 | 131,212 | 168,544 |
| Net Cash Flow | $-72,494 | $197,075 | $-36,910 | $-37,332 | $-43,030 |
| Free Cash Flow | |||||
| Operating Cash Flow | 301,465 | 292,281 | 269,745 | 212,506 | 169,782 |
| Capital Expenditure | -9 | -49 | -2 | -51 | N/A |
| Free Cash Flow | 301,456 | 292,232 | 269,743 | 212,455 | 169,782 |